TO COMPARE SERUM FRUCTOSAMINE AND HBA1C AS AN INDEX OF GLYCEMIC CONTROL IN DIABETIC HEMODIALYSIS PATIENT
International Journal of Drug Delivery Technology · 01.07.2026 · 16 (60s)
DOI: 10.25258/ijddt.16.60s.68 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 01.07.2026. Verfasst von Tushar R. Heda und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Assessment of glycemic control in diabetic patients with chronic kidney disease (CKD), particularly those undergoing hemodialysis (HD), is challenging. Glycated hemoglobin (HbA1c), the conventional marker of long-term glycemic control, may be unreliable in HD patients because of anemia, shortened erythrocyte lifespan, erythropoietin therapy, and frequent transfusions. Serum fructosamine (FA), reflecting glycemic status over the preceding 2–3 weeks, may provide a more accurate assessment in this population.
Aim
To study the comparison between “serum FA and HbA1c as an index of glycemic control in diabetic HD patients. Materials and Methods: A comparative cross-sectional study was conducted in the Department of General Medicine, Dr. D. Y. Patil Medical College and Hospital, Kolhapur, from January 2024 to December 2025. Adult diabetic CKD patients were categorized into Group A (non-hemodialysis CKD) and Group B (hemodialysis CKD). Clinical, biochemical, and renal function parameters were assessed. Serum fructosamine and HbA1c levels were measured and compared between groups. Correlation analysis between both glycemic markers and CKD stage was performed.
Results
The mean age of participants was 58.09 ± 8.98 years, with male predominance (67.2%). Group B exhibited significantly lower estimated glomerular filtration rate than Group A (10.39 ± 7.95 vs. 16.76 ± 5.24 mL/min/1.73 m²; p
Zitieren
APA
Heda, T. R., & Jotkar, S. K. (2026). TO COMPARE SERUM FRUCTOSAMINE AND HBA1C AS AN INDEX OF GLYCEMIC CONTROL IN DIABETIC HEMODIALYSIS PATIENT. International Journal of Drug Delivery Technology, 16(60s). https://doi.org/10.25258/ijddt.16.60s.68
Vancouver
Heda TR, Jotkar SK. TO COMPARE SERUM FRUCTOSAMINE AND HBA1C AS AN INDEX OF GLYCEMIC CONTROL IN DIABETIC HEMODIALYSIS PATIENT. International Journal of Drug Delivery Technology. 2026;16(60s). doi:10.25258/ijddt.16.60s.68
BibTeX
@article{Heda2026,
author = {Heda, Tushar R. and Jotkar, Sushama K.},
title = {TO COMPARE SERUM FRUCTOSAMINE AND HBA1C AS AN INDEX OF GLYCEMIC CONTROL IN DIABETIC HEMODIALYSIS PATIENT},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {60s},
doi = {10.25258/ijddt.16.60s.68}
}
EUVIMED